SEARCH

SEARCH BY CITATION

References

  • 1
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893917.
  • 2
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds (2010). AJCC Cancer Staging Manual, 7th edn. pp 14364. Springer, New York, NY.
  • 3
    Nelson H, Petrelli N, Carlin A et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93: 58396.
  • 4
    Lombardi L, Morelli F, Cinieri S et al. Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev 2010; 36(3): S3441.
  • 5
    NCCN Clinical Practice Guidelines in Oncology. http://www.nccn.org/ (accessed 17 November 2011).
  • 6
    Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 173140.
  • 7
    Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol 2008; 14: 377380.
  • 8
    Habr-Gama A, Perez R, Proscurshim I, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am 2010; 19: 82945.
  • 9
    Maas M, Nelemans PJ, Valentini V et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 83544.
  • 10
    FOxTROT Trial. University of Birmingham. UK. http.//www.foxtrot.bham.ac.uk/ (accessed 17 November 2011).
  • 11
    Annual Foxtrot. Annual Collaborators' Meeting- FOxTROT Trial. http.//www.nwlcn.nhs.uk/ (accessed 17 November 2011).
  • 12
    A Pilot Study of Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer. (NCT00826800). Memorial Sloan-Kettering Cancer Center. http://www.clinicaltrials.gov/ (accessed 17 November 2011).
  • 13
    Andre T, Boni C, Navarro M et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 310916.
  • 14
    Van Cutsem E, Labianca R, Bodoky G et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol 2009; 27: 1173125.
  • 15
    Ychou M, Raoul JL, Douillard JY et al. A phase III randomised trial of LV5FU2 +  irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). Ann Oncol 2009; 20: 67480.
  • 16
    Alberts SR, Sargent DJ, Nair S et al. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA 2012; 307: 138393.
  • 17
    Allegra CJ, Yothers G, O'Connell MJ et al. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol 2011; 29: 116.
  • 18
    Trarbach T, Kubicka S, Hacker U, Ridwelski K, Reinacher-Schick A. Adjuvant therapy of colon carcinoma. Onkologie 2008; 31(Suppl 5): 1923.
  • 19
    Hendren S, Birkmeyer JD, Yin H, Banerjee M, Sonnenday C, Morris AM. Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer. Dis Colon Rectum 2010; 53(12): 158793.
  • 20
    Benson AB III, Schrag D, Somerfield MR et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22: 340819.
  • 21
    Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 2004; 22: 3395407.
  • 22
    Bayraktar UD, Chen E, Bayraktar S et al. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? Cancer 2011; 117: 236470. doi:10.1002/cncr.25720.
  • 23
    Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 2011; 305(22): 233542.
  • 24
    Dighe S, Swift I, Magill L et al. Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience. Colorectal Dis 2012; 14: 43844.
  • 25
    Huh JW, Jeong YY, Kim HR, Kim YJ. Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer. Ann Oncol 2012; 23: 1198206.
  • 26
    Cascini GL, Avallone A, Delrio P et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006; 47: 12418.